Ganymede is a low-code PaaS for biotech software engineering that enables users to connect apps, ingest data, and construct pipelines.
Ganymede has raised $12.8M in total funding. The most recent round was Series A. The last funding was announced in August 2022.
Ganymede's investors include BoxGroup, Caffeinated Capital, SciFi VC.
Ganymede is headquartered in Palo Alto, United States.
Ganymede is a low-code PaaS for biotech software engineering that enables users to connect apps, ingest data, and construct pipelines.
Ganymede is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ganymede — Funding & Investors." VCBacked, August 9, 2022, https://www.vcbacked.co/company/ganymede. Accessed August 15, 2026.
VCBacked. (2022). Ganymede — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/ganymede
{{cite web |title=Ganymede — Funding & Investors |url=https://www.vcbacked.co/company/ganymede |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated